In addition, MET gene amplification and/or protein overexpression are frequent in cancer, accelerating research on intratumoral MET gene copy number or circulating soluble DNA, intratumoral MET protein content, and phosphorylation (activation) status [37]. This evidence concerns the gene MET and cancer.